Antibody-drug conjugates for the treatment of lymphoma: clinical advances and latest progress

Overview of attention for article published in Journal of Hematology & Oncology, June 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (74th percentile)
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

Mentioned by

twitter: 6 X users

patent: 2 patents

Citations

dimensions_citation: 45 Dimensions

Readers on

mendeley: 67 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 2 patents that reference this research output.

COMBINATION THERAPY USING ANTIBODY-DRUG CONJUGATES

Application WO-2023274974-A1

World Intellectual Property Organisation (WIPO)

COMBINATION-THERAPY ANTIBODY DRUG CONJUGATE WITH IMMUNE CELL INHIBITOR

Application WO-2022098972-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.